BioCentury
ARTICLE | Clinical News

ADI-PEG 20: Phase I started

February 9, 2015 8:00 AM UTC

Polaris began an open-label, U.S. Phase I trial to evaluate ADI-PEG 20 in combination with FOLFOX chemotherapy in about 22 patients. ...